Screening of Korean traditional herbal medicines with inhibitory activity on advanced glycation end products (AGEs) formation

Korean Journal of Pharmacognosy

Volumn 37, Issue 1, 2006, Pages 48-52

  Dae, Sik Jang ^a   Yun, Mi Lee ^a   Young, Sook Kim ^a   Jin, Sook Kim ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Advanced glycation end products (AGEs); Diabetic complications; Herbal medicines

Indexed keywords

AMINOGUANIDINE; AMMOMI TSAO KO FRUCTUS EXTRACT; AMOMI SEMEN EXTRACT; ARTEMISIAE ARGYI HERBA EXTRACT; CINNAMOMI CORTEX EXTRACT; LYCOPI HERBA EXTRACT; MENTHAE HERBA EXTRACT; NELUMBINIS SEMEN EXTRACT; PLANT EXTRACT; POLYGONI AVICULARIS HERBA EXTRACT; SALVIAE RADIX EXTRACT; UNCLASSIFIED DRUG;

AMMOMI TSAO KO FRUCTUS; AMOMI SEMEN; ARTEMISIA; ARTICLE; CINNAMON; DIABETES MELLITUS; DRUG INHIBITION; DRUG SCREENING; GLYCATION; HERBAL MEDICINE; IN VITRO STUDY; LYCOPI HERBA; MENTHAE HERBA; NELUMBINIS SEMEN; POLYGONI AVICULARIS HERBA; SALVIA; TRADITIONAL MEDICINE;

EID: 33645981271     PISSN: 02533073     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sakurai, T. and Tsuchiya, S. (1988) Superoxide production from nonenzymatically glycated protein. FEBS Lett. 236: 406-410.
2. Shinohara, R., Mano, T., Nagasaka, A., Sawai, Y., Uchimura, K., Hayashi, R., Hayakawa, N., Nagata, M., Makino, M., Kakizawa, H., Itoh, Y., Nakai, A. and Itoh, M. (1998) Effects of thyroid hormone on the sorbitol pathway in streptozotocin-induced diabetic rats. Biochim. Biophys. Acta 1425: 577-586.
3. Larkins, R.G. and Dunlop, M.E. (1992) The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35: 499-504.
4. Forbes, J.M., Cooper, M.E., Oldfield, M.D. and Thomas, M.C. (2003) Role of advanced glycation end products in diabetic nephropathy. J. Am. Soc. Nephrol. 14: S254-S258.
5. Bierhaus, A., Hofmann M.A., Ziegler, R. and Nawroth, P. (1998) AGEs and their interaction with AGE-receptors in vascular disease and diabetic mellitus. I. The AGE concept. Cardiovasc. Res. 37: 586-600.
6. Brownlee, M. (1996) Advanced glycation endproducts in diabetic complications. Curr. Opinion Endocrinol Diabetes 3: 291-297.
7. Rahbar, S. and Figarola, J.L. (2003) Novel inhibitors of advanced glycation endproducts. Arch. Biochem. Biophys. 419: 63-79.
8. Yokozawa, T., Nakagawa, T. and Terasawa, K. (2001) Effects of Oriental medicines on the production of advanced glycation endproducts. J. Trad. Med. 18: 107-112.
9. Kim, J.S., Kim, H. and Ko, J.H. (2002) Studies on the processing of herbal medicines (III)-HPLC analysis of magnolol and inhibitory effects on the formation of advanced glycation endproducts (AGEs) in vitro of unprocessed and processed Magnolia Bark. Kor. J. Pharmacogn. 33: 308-311.
10. Vinson, J.A. and Howard III, T.B. (1996) Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J. Nutr. Biochem. 7: 659-663.
11. Nakagawa, T., Yokozawa, T. and Terasawa, K. (2001) A study of Kampo medicines in a diabetic nephropathy model. J. Trad. Med. 18: 161-168.
12. Matsuda, H., Wang, T., Managi, H. and Yoshikawa, M. (2003) Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem. 11: 5317-5323.
13. Jung, Y.S., Joe, B.Y., Cho, S.J. and Konishi, Y. (2005) 2,3-Dimethoxy-5-methyl-1,4-benzoquinones and 2-methyl-1,4-naphthoquinones: Glycation inhibitors with lipid peroxidation activity. Bioorg. Med. Chem. 15: 1125-1129.